Dimitrios Chondros

No más puestos en curso

61 años

Health Technology

Consumer Services

Perfil

Dimitrios Chondros worked as a Medical Director at Cell Genesys, Inc. and as a Member-Antiangiogenesis at Genentech, Inc. He also served as the Chief Medical Officer & Senior Vice President at Halozyme Therapeutics, Inc. from 2017 to 2020.
Chondros holds a doctorate degree from the University of Zurich.

Antiguos cargos conocidos de Dimitrios Chondros.

Empresas	Cargo	Fin
HALOZYME THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/01/2020
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Corporate Officer/Principal	-
Cell Genesys, Inc. Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Dimitrios Chondros.

Formación de Dimitrios Chondros.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dimitrios Chondros.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Cell Genesys, Inc. Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services